PPARG and diabetes mellitus: In addition, pioglitazone, a PPAR-γ agonis widely used in clinical diabetes treatments has been shown to induce PPARγ expression and down-regulate the invasion genes snail transcription factor 1 (SLUG), MMP-9, and Vimentin, thus inhibiting the proliferation and migration of ECs and VSMCs in AVF [143].